Ieq Capital LLC Makes New Investment in LifeStance Health Group, Inc. $LFST

Ieq Capital LLC purchased a new stake in LifeStance Health Group, Inc. (NASDAQ:LFST) during the second quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm purchased 180,656 shares of the company’s stock, valued at approximately $1,935,000.

A number of other institutional investors and hedge funds have also modified their holdings of the company. Royal Bank of Canada grew its stake in LifeStance Health Group by 63.4% in the 1st quarter. Royal Bank of Canada now owns 70,248 shares of the company’s stock valued at $468,000 after buying an additional 27,244 shares during the last quarter. AQR Capital Management LLC lifted its position in LifeStance Health Group by 223.0% during the 1st quarter. AQR Capital Management LLC now owns 51,500 shares of the company’s stock worth $343,000 after acquiring an additional 35,554 shares during the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. boosted its holdings in LifeStance Health Group by 3.0% during the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 142,950 shares of the company’s stock valued at $952,000 after acquiring an additional 4,169 shares during the period. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC boosted its holdings in LifeStance Health Group by 1.9% during the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 615,652 shares of the company’s stock valued at $4,100,000 after acquiring an additional 11,331 shares during the period. Finally, JPMorgan Chase & Co. grew its position in shares of LifeStance Health Group by 10.2% in the second quarter. JPMorgan Chase & Co. now owns 550,657 shares of the company’s stock valued at $2,847,000 after purchasing an additional 51,154 shares during the last quarter. 85.50% of the stock is currently owned by institutional investors and hedge funds.

LifeStance Health Group Stock Performance

LifeStance Health Group stock opened at $12.28 on Wednesday. The firm has a market capitalization of $4.76 billion, a P/E ratio of 94.47 and a beta of 1.14. The stock has a fifty day moving average price of $10.99 and a two-hundred day moving average price of $8.49. LifeStance Health Group, Inc. has a 52-week low of $4.77 and a 52-week high of $12.97. The company has a debt-to-equity ratio of 0.18, a current ratio of 1.38 and a quick ratio of 1.38.

LifeStance Health Group (NASDAQ:LFST) last announced its quarterly earnings results on Thursday, August 6th. The company reported $0.06 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.03 by $0.03. The firm had revenue of $435.35 million during the quarter, compared to the consensus estimate of $414.58 million. LifeStance Health Group had a net margin of 3.19% and a return on equity of 3.39%. The firm’s quarterly revenue was up 26.1% on a year-over-year basis. During the same period last year, the firm posted ($0.01) EPS. As a group, analysts anticipate that LifeStance Health Group, Inc. will post 0.16 EPS for the current fiscal year.

Analysts Set New Price Targets

A number of equities analysts have recently commented on the company. JPMorgan Chase & Co. lifted their price objective on LifeStance Health Group from $9.00 to $13.00 and gave the stock a “neutral” rating in a research note on Friday, August 14th. The Goldman Sachs Group assumed coverage on LifeStance Health Group in a report on Friday, June 5th. They issued a “neutral” rating and a $9.00 target price on the stock. Zacks Research downgraded LifeStance Health Group from a “strong-buy” rating to a “hold” rating in a research report on Monday, July 13th. KeyCorp upped their price target on LifeStance Health Group from $11.00 to $13.00 and gave the stock an “overweight” rating in a report on Monday, July 13th. Finally, Wall Street Zen upgraded shares of LifeStance Health Group from a “buy” rating to a “strong-buy” rating in a research note on Saturday, August 15th. One analyst has rated the stock with a Strong Buy rating, six have issued a Buy rating and four have assigned a Hold rating to the company. According to MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $12.38.

Insiders Place Their Bets

In other LifeStance Health Group news, COO Lisa K. Miller sold 47,912 shares of LifeStance Health Group stock in a transaction on Monday, August 10th. The stock was sold at an average price of $10.85, for a total value of $519,845.20. Following the completion of the transaction, the chief operating officer owned 281,289 shares in the company, valued at approximately $3,051,985.65. The trade was a 14.55% decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, major shareholder Tpg Gp A, Llc sold 13,643,207 shares of the business’s stock in a transaction on Monday, August 10th. The stock was sold at an average price of $10.62, for a total value of $144,890,858.34. Following the completion of the transaction, the insider directly owned 98,101,407 shares in the company, valued at approximately $1,041,836,942.34. This represents a 12.21% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Over the last quarter, insiders sold 14,629,850 shares of company stock valued at $154,952,012. Company insiders own 3.50% of the company’s stock.

About LifeStance Health Group

LifeStance Health Group (NASDAQ:LFST) is a leading provider of outpatient mental health services in the United States. Headquartered in New York City, the company operates a growing network of clinics that deliver integrated, patient-centered psychological and psychiatric care. LifeStance’s mission is to expand access to high-quality mental health treatment by combining evidence-based therapy modalities with personalized treatment plans.

The company’s service offerings include individual, family, and group psychotherapy, psychiatric medication management, psychological assessment, and telehealth services.